But FGF1-mediated normalizing hyperglycemia may not the only contributed factor for FGF1 treating DICD, which may explain why FGF1 treatment exerts a better neuroprotective role for DICD when comparing with that in metformin treatment group. This evidence concerns the gene FGF1 and Hyperglycemia.